FDA.reportPublic FDA data

ETHINYL ESTRADIOL

Substance profile for UNII 423D2T571U, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ETHINYL ESTRADIOL
Structure render from PubChem CID 5991

Substance Identity#

UNII
423D2T571U
Preferred term
ETHINYL ESTRADIOL
Registry number
57-63-6
EC number
200-342-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C20H24O2
Chemical structure for ETHINYL ESTRADIOL
Structure render from PubChem CID 5991

Chemical And Database Identifiers#

InChIKey
BFPYWIDHMRZLRN-SLHNCBLASA-N
SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1CC[C@@]2(O)C#C
RxCUI
4124
PubChem
5991
NCIt
C486
INN ID
437

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5991https://pubchem.ncbi.nlm.nih.gov/compound/5991
PubChem InChIKey SearchBFPYWIDHMRZLRN-SLHNCBLASA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=BFPYWIDHMRZLRN-SLHNCBLASA-N
RxNorm4124https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=4124
NCI ThesaurusC486https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C486
FDA Substance Registration System423D2T571Uhttps://precision.fda.gov/uniisearch/srs/unii/423D2T571U
European Community number200-342-2https://commonchemistry.cas.org/results?q=200-342-2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571ULomedia 24 Fe6
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571ULomedia 24 Fe6
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UWYMZYA™Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UWYMZYA™Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UFalessa Kit5
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UFalessa Kit5
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UDELYLA™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UDELYLA™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UZenchent FE2
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UZenchent FE2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UPirmella™ 1/35 (norethindrone and ethinyl estradiol tablets USP) 1 mg/0.035 mg Rx Only5
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UPirmella™ 1/35 (norethindrone and ethinyl estradiol tablets USP) 1 mg/0.035 mg Rx Only5
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UWYMZYA TM Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UWYMZYA TM Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UNortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, USP 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UNortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, USP 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg)1
ethinyl estradiolACTIVE MOIETY423D2T571UTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ethinyl estradiolACTIVE INGREDIENT423D2T571UTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UVelivet ™ (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen) Rx only PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES.2
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UVelivet ™ (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen) Rx only PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES.2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UWATSONPHARMA Revised: April 2007 IN-5351/S Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UWATSONPHARMA Revised: April 2007 IN-5351/S Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UMICROGESTIN ® 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. MICROGESTIN ® 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. Rx o1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UMICROGESTIN ® 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. MICROGESTIN ® 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. Rx o1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.3
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.3
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UNorgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg5
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UNorgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg5
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UZovia 1/35E-28 Zovia 1/50E-28 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP) Revised: August 2006 Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UThese highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UThese highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UThese highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. Initial U.S. Approval: 20012
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UThese highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. Initial U.S. Approval: 20012
ethinyl estradiolACTIVE INGREDIENT423D2T571UORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol)2
ethinyl estradiolACTIVE MOIETY423D2T571UORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol)2
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571U7abf2fff-f612-4842-9d1d-375af93f42591
ethinyl estradiolACTIVE INGREDIENT423D2T571UNUVARING ® (etonogestrel/ethinyl estradiol vaginal ring)2
ethinyl estradiolACTIVE MOIETY423D2T571UNUVARING ® (etonogestrel/ethinyl estradiol vaginal ring)2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UThese highlights do not include all the information needed to use LoSeasonique tablets safely and effectively. See full prescribing information for LoSeasonique. LoSeasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19822
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UThese highlights do not include all the information needed to use LoSeasonique tablets safely and effectively. See full prescribing information for LoSeasonique. LoSeasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19822
ethinyl estradiolACTIVE INGREDIENT423D2T571UNECON 7/7/7 ® Tablets (norethindrone/ethinyl estradiol)2
ethinyl estradiolACTIVE MOIETY423D2T571UNECON 7/7/7 ® Tablets (norethindrone/ethinyl estradiol)2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571Unorethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571Unorethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets 0.4 mg/35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571URevised: November 2007 IN-5427/S PHYSICIAN LABELING Trivora ® (levonorgestrel and ethinyl estradiol tablets USP) triphasic regimen Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571URevised: November 2007 IN-5427/S PHYSICIAN LABELING Trivora ® (levonorgestrel and ethinyl estradiol tablets USP) triphasic regimen Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UOCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UOCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UJinteli TM (northindrone acetate and ethinyl estradiol tablets, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UJinteli TM (northindrone acetate and ethinyl estradiol tablets, USP)1
ethinyl estradiolACTIVE INGREDIENT423D2T571UORTHO TRI-CYCLEN ® Lo Tablets (norgestimate/ethinyl estradiol)4
ethinyl estradiolACTIVE MOIETY423D2T571UORTHO TRI-CYCLEN ® Lo Tablets (norgestimate/ethinyl estradiol)4
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571U709031e4-4c20-4ea7-beff-6c459709a4331
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571U709031e4-4c20-4ea7-beff-6c459709a4331
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UKelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP)2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UKelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP)2
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UApri ® (desogestrel and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UApri ® (desogestrel and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UCRYSELLE™ - 28 TABLETS (NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UCRYSELLE™ - 28 TABLETS (NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571USprintec ® (norgestimate and ethinyl estradiol tablets) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571USprintec ® (norgestimate and ethinyl estradiol tablets) Rx only1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UKariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UKariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UGianvi TM (drospirenone and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UGianvi TM (drospirenone and ethinyl estradiol) Tablets1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UZenchent® 0.4/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4 mg/0.035 mg, 28-Day)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UZenchent® 0.4/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4 mg/0.035 mg, 28-Day)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UGianvi™ (drospirenone and ethinyl estradiol tablets) Rev. D 6/2010 110016851
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UGianvi™ (drospirenone and ethinyl estradiol tablets) Rev. D 6/2010 110016851
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UThese highlights do not include all the information needed to use Seasonique safely and effectively. See full prescribing information for Seasonique. Seasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19821
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UThese highlights do not include all the information needed to use Seasonique safely and effectively. See full prescribing information for Seasonique. Seasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19821
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571U4cafa90a-9903-40d0-b8be-6ad78018b4b61
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571U4cafa90a-9903-40d0-b8be-6ad78018b4b61
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UFEMCON ® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg / 35 mcg1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UFEMCON ® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg / 35 mcg1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571Ufemhrt ® (norethindrone acetate/ethinyl estradiol tablets)1
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571Ufemhrt ® (norethindrone acetate/ethinyl estradiol tablets)1
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UGILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UGILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UGILDAGIA (NORETHINDRONE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]17
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UGILDAGIA (NORETHINDRONE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]17
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UGILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UGILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UTRI PREVIFEM (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]15
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UTRI PREVIFEM (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]15
ETHINYL ESTRADIOLACTIVE INGREDIENT423D2T571UMYZILRA (LEVONORGESTREL AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]14
ETHINYL ESTRADIOLACTIVE MOIETY423D2T571UMYZILRA (LEVONORGESTREL AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]14